The global stem cell therapy market size is estimated at USD 18.13 billion in 2025 and is forecasted to reach around USD 54.15 billion by 2034, accelerating at a CAGR of 12.95% from 2025 to 2034. The North America stem cell therapy market size was reached USD 8.65 billion in 2024 and is expanding at a CAGR of 12.95% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Stem Cell Therapy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Stem Cell Therapy Market, by Product
8.1.1. Adult Stem Cells (ASCs)
8.1.1.1. Market Revenue and Forecast
8.1.2. Human Embryonic Stem Cells (HESCs)
8.1.2.1. Market Revenue and Forecast
8.1.3. Induced Pluripotent Stem Cells (iPSCs)
8.1.3.1. Market Revenue and Forecast
8.1.4. Very Small Embryonic Like Stem Cells
8.1.4.1. Market Revenue and Forecast
9.1. Stem Cell Therapy Market, by Therapy Type
9.1.1. Autologous
9.1.1.1. Market Revenue and Forecast
9.1.2. Allogenic
9.1.2.1. Market Revenue and Forecast
10.1. Stem Cell Therapy Market, by Application
10.1.1. Regenerative Medicine
10.1.1.1. Market Revenue and Forecast
10.1.2. Drug Discovery and Development
10.1.2.1. Market Revenue and Forecast
11.1. Stem Cell Therapy Market, by Technology
11.1.1. Cell Acquiition
11.1.1.1. Market Revenue and Forecast
11.1.2. Cell Production
11.1.2.1. Market Revenue and Forecast
11.1.3. Cryopreservation
11.1.3.1. Market Revenue and Forecast
11.1.4. Expansion and Sub-Culture
11.1.4.1. Market Revenue and Forecast
12.1. Stem Cell Therapy Market, by End User
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast
12.1.2. Research institutes
12.1.2.1. Market Revenue and Forecast
12.1.3. surgical institutes
12.1.3.1. Market Revenue and Forecast
12.1.4. Orders
12.1.4.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product
13.1.2. Market Revenue and Forecast, by Therapy Type
13.1.3. Market Revenue and Forecast, by Application
13.1.4. Market Revenue and Forecast, by Technology
13.1.5. Market Revenue and Forecast, by End User
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product
13.1.6.2. Market Revenue and Forecast, by Therapy Type
13.1.6.3. Market Revenue and Forecast, by Application
13.1.6.4. Market Revenue and Forecast, by Technology
13.1.6.5. Market Revenue and Forecast, by End User
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product
13.1.7.2. Market Revenue and Forecast, by Therapy Type
13.1.7.3. Market Revenue and Forecast, by Application
13.1.7.4. Market Revenue and Forecast, by Technology
13.1.7.5. Market Revenue and Forecast, by End User
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product
13.2.2. Market Revenue and Forecast, by Therapy Type
13.2.3. Market Revenue and Forecast, by Application
13.2.4. Market Revenue and Forecast, by Technology
13.2.5. Market Revenue and Forecast, by End User
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product
13.2.6.2. Market Revenue and Forecast, by Therapy Type
13.2.6.3. Market Revenue and Forecast, by Application
13.2.6.4. Market Revenue and Forecast, by Technology
13.2.6.5. Market Revenue and Forecast, by End User
13.2.7. Germany
13.2.7.1. Market Revenue and Forecast, by Product
13.2.7.2. Market Revenue and Forecast, by Therapy Type
13.2.7.3. Market Revenue and Forecast, by Application
13.2.7.4. Market Revenue and Forecast, by Technology
13.2.7.5. Market Revenue and Forecast, by End User
13.2.8. France
13.2.8.1. Market Revenue and Forecast, by Product
13.2.8.2. Market Revenue and Forecast, by Therapy Type
13.2.8.3. Market Revenue and Forecast, by Application
13.2.8.4. Market Revenue and Forecast, by Technology
13.2.8.5. Market Revenue and Forecast, by End User
13.2.9. Rest of Europe
13.2.9.1. Market Revenue and Forecast, by Product
13.2.9.2. Market Revenue and Forecast, by Therapy Type
13.2.9.3. Market Revenue and Forecast, by Application
13.2.9.4. Market Revenue and Forecast, by Technology
13.2.9.5. Market Revenue and Forecast, by End User
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product
13.3.2. Market Revenue and Forecast, by Therapy Type
13.3.3. Market Revenue and Forecast, by Application
13.3.4. Market Revenue and Forecast, by Technology
13.3.5. Market Revenue and Forecast, by End User
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product
13.3.6.2. Market Revenue and Forecast, by Therapy Type
13.3.6.3. Market Revenue and Forecast, by Application
13.3.6.4. Market Revenue and Forecast, by Technology
13.3.6.5. Market Revenue and Forecast, by End User
13.3.7. China
13.3.7.1. Market Revenue and Forecast, by Product
13.3.7.2. Market Revenue and Forecast, by Therapy Type
13.3.7.3. Market Revenue and Forecast, by Application
13.3.7.4. Market Revenue and Forecast, by Technology
13.3.7.5. Market Revenue and Forecast, by End User
13.3.8. Japan
13.3.8.1. Market Revenue and Forecast, by Product
13.3.8.2. Market Revenue and Forecast, by Therapy Type
13.3.8.3. Market Revenue and Forecast, by Application
13.3.8.4. Market Revenue and Forecast, by Technology
13.3.8.5. Market Revenue and Forecast, by End User
13.3.9. Rest of APAC
13.3.9.1. Market Revenue and Forecast, by Product
13.3.9.2. Market Revenue and Forecast, by Therapy Type
13.3.9.3. Market Revenue and Forecast, by Application
13.3.9.4. Market Revenue and Forecast, by Technology
13.3.9.5. Market Revenue and Forecast, by End User
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product
13.4.2. Market Revenue and Forecast, by Therapy Type
13.4.3. Market Revenue and Forecast, by Application
13.4.4. Market Revenue and Forecast, by Technology
13.4.5. Market Revenue and Forecast, by End User
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product
13.4.6.2. Market Revenue and Forecast, by Therapy Type
13.4.6.3. Market Revenue and Forecast, by Application
13.4.6.4. Market Revenue and Forecast, by Technology
13.4.6.5. Market Revenue and Forecast, by End User
13.4.7. North Africa
13.4.7.1. Market Revenue and Forecast, by Product
13.4.7.2. Market Revenue and Forecast, by Therapy Type
13.4.7.3. Market Revenue and Forecast, by Application
13.4.7.4. Market Revenue and Forecast, by Technology
13.4.7.5. Market Revenue and Forecast, by End User
13.4.8. South Africa
13.4.8.1. Market Revenue and Forecast, by Product
13.4.8.2. Market Revenue and Forecast, by Therapy Type
13.4.8.3. Market Revenue and Forecast, by Application
13.4.8.4. Market Revenue and Forecast, by Technology
13.4.8.5. Market Revenue and Forecast, by End User
13.4.9. Rest of MEA
13.4.9.1. Market Revenue and Forecast, by Product
13.4.9.2. Market Revenue and Forecast, by Therapy Type
13.4.9.3. Market Revenue and Forecast, by Application
13.4.9.4. Market Revenue and Forecast, by Technology
13.4.9.5. Market Revenue and Forecast, by End User
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product
13.5.2. Market Revenue and Forecast, by Therapy Type
13.5.3. Market Revenue and Forecast, by Application
13.5.4. Market Revenue and Forecast, by Technology
13.5.5. Market Revenue and Forecast, by End User
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product
13.5.6.2. Market Revenue and Forecast, by Therapy Type
13.5.6.3. Market Revenue and Forecast, by Application
13.5.6.4. Market Revenue and Forecast, by Technology
13.5.6.5. Market Revenue and Forecast, by End User
13.5.7. Rest of LATAM
13.5.7.1. Market Revenue and Forecast, by Product
13.5.7.2. Market Revenue and Forecast, by Therapy Type
13.5.7.3. Market Revenue and Forecast, by Application
13.5.7.4. Market Revenue and Forecast, by Technology
13.5.7.5. Market Revenue and Forecast, by End User
14.1. Caladrius
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. CELGENE CORPORATION
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. ReNeuron Group plc
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Virgin Health Bank
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Opexa Therapeutics, Inc
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Pluristem Therapeutics Inc
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. STEMCELL Technologies Inc.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Biovault family
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Precious Cells International Ltd
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Mesoblast Ltd
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample